Lapatinib Activates the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in HepG2 Cells

Frontiers in Pharmacology
Noëmi Johanna RoosStephan Krähenbühl

Abstract

The receptor tyrosine kinase inhibitor lapatinib, indicated to treat patients with HER2-positive breast cancer in combination with capecitabine, can cause severe hepatotoxicity. Lapatinib is further associated with mitochondrial toxicity and accumulation of reactive oxygen species. The effect of lapatinib on the Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, the major cellular defense pathway against oxidative stress, has so far not been studied in detail. In the present study, we show that lapatinib (2-20 µM) activates the Keap1-Nrf2 pathway in HepG2 cells, a hepatocellular carcinoma-derived cell line, in a concentration-dependent manner upon 24 h of treatment. Lapatinib stabilized the transcription factor Nrf2 at concentrations ≥5 µM and caused its nuclear translocation. Well-established Nrf2 regulated genes (Nqo1, Gsta1, Gclc, and Gclm) were upregulated at lapatinib concentrations ≥10 µM. Furthermore, cellular and mitochondrial glutathione (GSH) levels increased starting at 10 µM lapatinib. As a marker of oxidative stress, cellular GSSG significantly increased at 10 and 20 µM lapatinib. Furthermore, the gene expression of mitochondrial Glrx2 and SOD2 were increased upo...Continue Reading

References

Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·O W Griffith, A Meister
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 1, 2005·Cell·Robert S BalabanToren Finkel
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Martin OttBoris Zhivotovsky
Jul 20, 2007·Nature Reviews. Drug Discovery·Beverly MoyPaul Goss
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Quincy S C ChuEric K Rowinsky
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin M KochDebasish F Roychowdhury
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry L GomezGeorge W Sledge
Sep 23, 2008·Clinical Therapeutics·Patrick J Medina, Susan Goodin
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin M KochLionel D Lewis
Mar 17, 2009·Analytical Biochemistry·Hue-Tran Hornig-DoRudolf J Wiesner
Jan 13, 2010·Experimental Gerontology·Martin D Brand
Jul 14, 2010·Molecular Pharmacology·Woon Chien TengEric Chun Yong Chan
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Colin F SpraggsLon R Cardon
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eitan AmirAlberto Ocaña
Jun 3, 2011·World Journal of Gastroenterology : WJG·Stavros PeroukidesHaralabos Kalofonos
Oct 4, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephen CastellinoChristopher MacLauchlin
Nov 1, 2011·Free Radical Biology & Medicine·Hilla ErlankJoseph Kanner
Nov 9, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Andrea FelserStephan Krähenbühl
Aug 10, 2013·Nature Protocols·Daniela GiustariniRanieri Rossi
Nov 20, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hatem A AzimEvandro de Azambuja
Jul 6, 2014·Physiological Reviews·Dmitry B ZorovSteven J Sollott
Mar 10, 2016·Chemical Research in Toxicology·Marsha Rebecca EnoMichael D Cameron
Dec 6, 2016·Frontiers in Pharmacology·Benjamin BergerManuel Haschke
May 3, 2018·Physiological Reviews·Masayuki YamamotoHozumi Motohashi
Jul 18, 2019·Cell Reports·Takafumi SuzukiMasayuki Yamamoto

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
nuclear translocation
Protein Assay
electrophoresis
PCR
transfection

Software Mentioned

GraphPad
GraphPad prism
Analyst
Evolution Capture
ViiA7

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.